Probably not even worth listening to the conference call. I was a little off in my prediction of $2.1M. Good thing they have something to sell in the OTC Nasal Spray now. Otherwise there is no way that could make their $15M in Revs (just barely IMO) for 2017. I don't see anyway they will be profitable by end of 2017.
The people who get to ask the questions will most likely keep it simple and praise Dr. Da.